Generic Opana obtains federal approval

07/15/2013 | RTT News · Benzinga.com

The FDA has granted Actavis approval for its oxymorphone hydrochloride extended-release tablets in five strengths to treat moderate to severe pain in patients who need continuous around-the-clock opioid treatment. The drug is a generic version of Opana ER, made by Endo Health Solutions.

View Full Article in:

RTT News · Benzinga.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA